论文部分内容阅读
目的探讨奥扎格雷钠及曲克芦丁对急性脑梗死疗效的作用差异,为临床用药提供科学指导。方法将我院100例急性脑梗死患者随机分为两组各50例,奥扎格雷钠组进行连续14d,1次/d,40ml/次奥扎格雷钠注射液静脉滴注治疗,曲克芦丁组按相同方法使用曲克芦丁进行静脉滴注治疗。比较两组疗效。结果奥扎格雷钠组临床总有效率明显高于曲克芦丁组,组间差异有统计学意义(P<0.05)。同时奥扎格雷钠还具有副作用少的优点,安全率96.0%。结论奥扎格雷钠治疗急性脑梗死疗效显著,值得临床推广。
Objective To investigate the effect of ozagrel sodium and troxerutin on the curative effect of acute cerebral infarction and to provide scientific guidance for clinical medication. Methods 100 patients with acute cerebral infarction in our hospital were randomly divided into two groups of 50 cases, the ozagrel sodium group for 14 days, 1 / d, 40ml / Ozagrel sodium injection intravenous infusion treatment, Ding group by the same method using troxerutin for intravenous infusion therapy. Compare the two groups curative effect. Results The total effective rate of ozagrel sodium group was significantly higher than troxerutin group, the difference was statistically significant (P <0.05). Ozagrel sodium also has the advantage of less side effects, safety rate of 96.0%. Conclusion Ozagrel sodium treatment of acute cerebral infarction significant effect, worthy of clinical promotion.